BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6104627)

  • 1. In vitro and in vivo studies on glucagonoma tissue.
    Berger M; Teuscher A; Halban P; Trimble E; Studer PP; Wollheim CB; Zimmermann-Telschow H; Muller WA
    Horm Metab Res; 1980 Apr; 12(4):144-50. PubMed ID: 6104627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The course of diabetes and clinical findings in glucagonoma].
    Teuscher A; Studer PP; Krebs A; Berger M; Aeberhard P
    Schweiz Med Wochenschr; 1979 Sep; 109(35):1273-80. PubMed ID: 524094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.
    Cohen DM; Jaspan JB; Polonsky KS; Lever EG; Moossa AR
    Gastroenterology; 1984 Sep; 87(3):679-87. PubMed ID: 6146553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome.
    Bernstein M; Jahoor F; Townsend CM; Klein S
    Metabolism; 2001 Jun; 50(6):720-2. PubMed ID: 11398151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hyperglucagonemia--an autosomal dominant disorder.
    Boden G; Owen OE
    N Engl J Med; 1977 Mar; 296(10):534-8. PubMed ID: 189188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
    Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
    J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant inheritance of large molecular weight immunoreactive glucagon.
    Palmer JP; Werner PL; Benson JW; Ensinck JW
    J Clin Invest; 1978 Mar; 61(3):763-9. PubMed ID: 641153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucagonoma: case report and literature review].
    das Neves MM; Martins Júnior EV; Gaburri AK; Chebli JM; Stávale JN; Herani Filho AK
    Arq Gastroenterol; 1996; 33(3):167-72. PubMed ID: 9201330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
    von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
    Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic and hepatic response to carbohydrate ingestion.
    Waldhäusl WK; Bratusch-Marrain P
    Neth J Med; 1985; 28 Suppl 1():15-9. PubMed ID: 2861576
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of insulin and glucagon in the plasma aminoacid imbalance of chronic hepatic encephalopathy.
    Marchesini G; Zoli M; Forlani G
    Z Gastroenterol; 1979 Jul; 17(7):469-76. PubMed ID: 382661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
    Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
    Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.